To test whether BCL-2 is linked to the respiratory phenotype after lipid exposure, we treated PC-melanoma and YA-melanoma cells with the BCL-2 inhibitor ABT199,40 which significantly reduced OXPHOS (Figure S6C), indicating BCL-2 mediates OXPHOS after lipid and PC exposure. Here, BCL2 is linked to melanoma.